Reconstructed human small intestine and pigmented epidermis microtissue samples and culture media

Ended Purchase Order Awarded Last action

Contract number
75F40125P00097
Awardee
Awarding agency
Obligated
$39,857

Award facts

Opportunity
Contract value 100% obligated
$39,857.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Ashland, MA 01721, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $39,857

About this award

The Food and Drug Administration's National Center for Toxicological Research awarded a $39,857 firm fixed-price purchase order to Mattek Corporation, a small business specializing in advanced human tissue models. The contract, designated as a total small business set-aside and awarded on June 23, 2025, requires delivery of reconstructed human microtissue samples and associated culture media by December 31, 2025. Specifically, Mattek will supply 144 reconstructed human small intestine tissue samples and 144 pigmented epidermis samples, each with corresponding maintenance media, all meeting rigorous technical specifications for air-liquid interface culturing. The small intestine tissues must contain epithelial, endothelial, and fibroblast cells from human donors, while the pigmented epidermis samples must feature human keratinocytes and melanocytes derived from both Caucasian/White and African American/Black donors.

Mattek Corporation, headquartered in Ashland, Massachusetts, is a recognized manufacturer of sophisticated human and animal tissue models widely used across federal research agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and Department of the Navy. The company's specialized microtissue samples support critical biomedical research applications, including toxicological studies and disease modeling. This procurement represents a continuation of the FDA's ongoing investment in developing physiologically relevant in vitro research platforms that advance drug safety evaluation and reduce reliance on traditional animal testing methodologies.

Quick answers

Who was awarded contract 75F40125P00097?

75F40125P00097 was awarded to Mattek Corporation by Food and Drug Administration (Department of Health and Human Services) on June 23, 2025.

How much is contract 75F40125P00097 worth?

The government has obligated $39,857 on 75F40125P00097.

Was contract 75F40125P00097 competed?

The extent of competition for 75F40125P00097 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award